MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
3.400
0.000
0.00%
After Hours: 3.427 +0.027 +0.78% 19:30 09/11 EDT
OPEN
3.440
PREV CLOSE
3.400
HIGH
3.440
LOW
3.370
VOLUME
356.23K
TURNOVER
--
52 WEEK HIGH
5.06
52 WEEK LOW
1.620
MARKET CAP
147.21M
P/E (TTM)
-4.6227
1D
5D
1M
3M
1Y
5Y
1D
NRx Pharmaceuticals’ HOPE Therapeutics To Deploy Zeta Surgical's Newly FDA-Cleared Zeta TMS Robotic System, With Clinical Staff Now In Training Ahead Of Deployment In Florida
Benzinga · 1d ago
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
Barchart · 2d ago
Weekly Report: what happened at NRXP last week (0831-0904)?
Weekly Report · 5d ago
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), NRX Pharmaceuticals (NRXP) and Innate Pharma (IPHA)
TipRanks · 09/02 10:30
Weekly Report: what happened at NRXP last week (0824-0828)?
Weekly Report · 08/31 09:55
NRX Pharmaceuticals Price Target Maintained With a $45.00/Share by HC Wainwright & Co.
Dow Jones · 08/25 16:58
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target
Benzinga · 08/25 16:48
Weekly Report: what happened at NRXP last week (0817-0821)?
Weekly Report · 08/24 09:56
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.